BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18176174)

  • 1. Effect of 1,25(OH)2-vitamin D on bone mass in children with acute lymphoblastic leukemia.
    Díaz PR; Neira LC; Fischer SG; Teresa Torres MC; Milinarsky AT; Giadrosich VR; Arriagada MM; Arinoviche RS; Casanova DM
    J Pediatr Hematol Oncol; 2008 Jan; 30(1):15-9. PubMed ID: 18176174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
    Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
    J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased bone mineral density in young adults treated with SCT in childhood: the role of 25-hydroxyvitamin D.
    Frisk P; Arvidson J; Ljunggren O; Gustafsson J
    Bone Marrow Transplant; 2012 May; 47(5):657-62. PubMed ID: 21765478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitriol treatment in patients with low vitamin D levels.
    Tanakol R; Gül N; Üzüm AK; Aral F
    Arch Osteoporos; 2018 Oct; 13(1):114. PubMed ID: 30353299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
    Wiernikowski JT; Barr RD; Webber C; Guo CY; Wright M; Atkinson SA
    J Oncol Pharm Pract; 2005 Jun; 11(2):51-6. PubMed ID: 16460605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of oral 1 alpha-hydroxycalciferol treatment on bone mineral density in hemodialysis patients.
    Morita A; Tabata T; Inoue T; Nishizawa Y; Morii H
    Clin Nephrol; 1996 Dec; 46(6):389-93. PubMed ID: 8982555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial.
    Matsumoto T; Miki T; Hagino H; Sugimoto T; Okamoto S; Hirota T; Tanigawara Y; Hayashi Y; Fukunaga M; Shiraki M; Nakamura T
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5031-6. PubMed ID: 15972580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant increase in muscle strength and bone mineral density with decreasing IL-6 levels after combination therapy with alendronate and calcitriol in postmenopausal women.
    Park JH; Park KH; Cho S; Choi YS; Seo SK; Lee BS; Park HS
    Menopause; 2013 Jul; 20(7):747-53. PubMed ID: 23511701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
    Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia.
    Gunes AM; Can E; Saglam H; Ilçöl YO; Baytan B
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia.
    Tillmann V; Darlington AS; Eiser C; Bishop NJ; Davies HA
    J Bone Miner Res; 2002 Jun; 17(6):1073-80. PubMed ID: 12054163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis lung disease.
    Donovan DS; Papadopoulos A; Staron RB; Addesso V; Schulman L; McGregor C; Cosman F; Lindsay RL; Shane E
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1892-9. PubMed ID: 9620924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia.
    Hartman A; te Winkel ML; van Beek RD; de Muinck Keizer-Schrama SM; Kemper HC; Hop WC; van den Heuvel-Eibrink MM; Pieters R
    Pediatr Blood Cancer; 2009 Jul; 53(1):64-71. PubMed ID: 19283791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial.
    Chevrel G; Schott AM; Fontanges E; Charrin JE; Lina-Granade G; Duboeuf F; Garnero P; Arlot M; Raynal C; Meunier PJ
    J Bone Miner Res; 2006 Feb; 21(2):300-6. PubMed ID: 16418786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density in survivors of childhood acute lymphoblastic leukemia.
    Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Papageorgiou T; Papastergiou C; Tsituridis I; Koliouskas D
    Turk J Pediatr; 2006; 48(2):101-4. PubMed ID: 16848106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct X-ray radiogrammetry versus dual-energy X-ray absorptiometry: assessment of bone density in children treated for acute lymphoblastic leukaemia and growth hormone deficiency.
    van Rijn RR; Boot A; Wittenberg R; van der Sluis IM; van den Heuvel-Eibrink MM; Lequin MH; de MuinckKeizer-Schrama SM; Van Kuijk C
    Pediatr Radiol; 2006 Mar; 36(3):227-32. PubMed ID: 16432701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of bone metabolism in children with acute lymphoblastic leukemia after induction chemotherapy treatment.
    Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Koliouskas D; Papastergiou C; Tsituridis I
    Pediatr Hematol Oncol; 2005 Jun; 22(4):285-9. PubMed ID: 16020115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.